文献速递妇科产科

早期宫颈癌保留生育功能手术后首次妊娠的结局

Outcomes of the First Pregnancy After Fertility-Sparing Surgery for Early-Stage Cervical Cancer.
PubMed 文献 · Obstet Gynecol · 2021-01-01

基于加州癌症登记(2000-2012)的队列研究,纳入118例早期宫颈癌保留生育功能手术(宫颈锥切或LEEP)后妊娠患者,107例符合标准并以1:2匹配对照组。结果显示病例组37周前早产风险高于无癌人群(21.5% vs 9.3%,OR 2.7,95%CI 1.4-5.1)和癌前分娩人群(21.5% vs 12.7%,OR 1.9,95%CI 1.0-3.6),但32周前早产无差异。新生儿发病率高于癌前分娩对照组(15.9% vs 6.9%,OR 2.5,95%CI 1.2-5.5),其他结局无差异。

要点

  • 宫颈锥切或LEEP后妊娠的37周前早产风险显著增加(OR 2.7和1.9)
  • 32周前早产、胎儿生长受限、死产、剖宫产及母亲严重发病率无差异
  • 新生儿发病率高于癌前分娩对照组(15.9% vs 6.9%)

核心结论

  • 早期宫颈癌保留生育功能手术后妊娠的患者,与无癌人群及癌前分娩人群相比,37周前早产风险升高,但32周前早产风险无差异。

研究设计与样本

  • 基于加州癌症登记(2000-2012)的队列研究,纳入18-45岁I期宫颈癌患者,要求保留生育功能手术(宫颈锥切或LEEP)后至少3个月妊娠,排除宫颈切除术者。
  • 共118例(2.9%)患者术后妊娠,107例符合标准并纳入分析,以1:2比例倾向性评分匹配无癌人群和癌前分娩的宫颈癌患者作为对照。

主要发现

  • 病例组37周前早产率21.5%,高于无癌对照组9.3%(OR 2.7,95%CI 1.4-5.1)和癌前分娩对照组12.7%(OR 1.9,95%CI 1.0-3.6)。
  • 病例组新生儿发病率15.9%,高于癌前分娩对照组6.9%(OR 2.5,95%CI 1.2-5.5)。
  • 两组间胎儿生长受限、死产、剖宫产及母亲严重发病率无差异;32周前早产无差异。
  • 最常见组织学类型为鳞癌(63.2%),其次为腺癌(30.8%)。

临床怎么用

  • 对早期宫颈癌保留生育功能手术后妊娠者,应加强早产监测与预防管理,并关注新生儿结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate outcomes of the first pregnancy after fertility-sparing surgery in patients with early-stage cervical cancer. METHODS: We performed a population-based study of women aged 18-45 years with a history of stage I cervical cancer reported to the 2000-2012 California Cancer Registry. Data were linked to the OSHPD (California Office of Statewide Health Planning and Development) birth and discharge data sets. We included patients with cervical cancer who conceived at least 3 months after a fertility-sparing surgery, which included cervical conization or loop electrosurgical excision procedure. Those undergoing trachelectomy were excluded. The primary outcome was preterm birth. Secondary outcomes included growth restriction, neonatal morbidity, stillbirth, cesarean delivery, and severe maternal morbidity. We used propensity scores to match similar women from two groups in a 1:2 ratio of case group participants to control group participants: population individuals without cancer and individuals with cervical cancer (women who delivered before their cervical cancer diagnosis). Wald statistics and logistic regressions were used to evaluate outcomes. RESULTS: Of 4,087 patients with cervical cancer, 118 (2.9%) conceived after fertility-sparing surgery, and 107 met inclusion criteria and were matched to control group participants. Squamous cell carcinoma was the most common histology (63.2%), followed by adenocarcinoma (30.8%). Patients in the case group had higher odds of preterm birth before 37 weeks of gestation compared with both control groups (21.5% vs 9.3%, odds ratio [OR] 2.7, 95% CI 1.4-5.1; 21.5% vs 12.7%, OR 1.9, 95% CI 1.0-3.6), but not preterm birth before 32 weeks. Neonatal morbidity was more common among the patients in the case group relative to those in the cervical cancer control group (15.9% vs 6.9%, OR 2.5, 95% CI 1.2-5.5). There were no differences in rates of growth restriction, stillbirth, cesarean delivery, and maternal morbidity. CONCLUSION: In a population-based cohort, patients who conceived after surgery for cervical cancer had higher odds of preterm delivery compared with control groups.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Nitecki R, Floyd J, Lamiman K, et al. Outcomes of the First Pregnancy After Fertility-Sparing Surgery for Early-Stage Cervical Cancer. Obstet Gynecol. 2021. PMID: 34623068. doi:10.1097/AOG.0000000000004532

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。